Prospective observational study and serosurvey of SARS-CoV-2 infection in asymptomatic healthcare workers at a Canadian tertiary care center.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 02 11 2020
accepted: 03 02 2021
entrez: 16 2 2021
pubmed: 17 2 2021
medline: 27 2 2021
Statut: epublish

Résumé

Health care workers (HCWs) are at higher risk for SARS-CoV-2 infection and may play a role in transmitting the infection to vulnerable patients and members of the community. This is particularly worrisome in the context of asymptomatic infection. We performed a cross-sectional study looking at asymptomatic SARS-CoV-2 infection in HCWs. We screened asymptomatic HCWs for SARS-CoV-2 via PCR. Complementary viral genome sequencing was performed on positive swab specimens. A seroprevalence analysis was also performed using multiple assays. Asymptomatic health care worker cohorts had a combined swab positivity rate of 29/5776 (0.50%, 95%CI 0.32-0.75) relative to a comparative cohort of symptomatic HCWs, where 54/1597 (3.4%) tested positive for SARS-CoV-2 (ratio of symptomatic to asymptomatic 6.8:1). SARS-CoV-2 seroprevalence among 996 asymptomatic HCWs with no prior known exposure to SARS-CoV-2 was 1.4-3.4%, depending on assay. A novel in-house Coronavirus protein microarray showed differing SARS-CoV-2 protein reactivities and helped define likely true positives vs. suspected false positives. Our study demonstrates the utility of routine screening of asymptomatic HCWs, which may help to identify a significant proportion of infections.

Identifiants

pubmed: 33592074
doi: 10.1371/journal.pone.0247258
pii: PONE-D-20-34493
pmc: PMC7886177
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0247258

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Lancet. 2020 May 2;395(10234):1418-1420
pubmed: 32305073
J Clin Virol. 2020 Aug;129:104468
pubmed: 32485620
J Clin Microbiol. 2020 Jul 23;58(8):
pubmed: 32381641
JAMA. 2020 Apr 14;323(14):1406-1407
pubmed: 32083643
Science. 2020 May 1;368(6490):489-493
pubmed: 32179701
PLoS One. 2020 Jun 25;15(6):e0235417
pubmed: 32584894
Lancet. 2020 May 2;395(10234):e77-e78
pubmed: 32333843
Lancet Public Health. 2020 Sep;5(9):e475-e483
pubmed: 32745512
J Vis Exp. 2016 Sep 15;(115):
pubmed: 27685156
Nat Commun. 2020 Jul 8;11(1):3500
pubmed: 32641730
Ann Intern Med. 2020 Sep 1;173(5):362-367
pubmed: 32491919
Cell. 2020 Aug 20;182(4):812-827.e19
pubmed: 32697968
J Hosp Infect. 2020 Aug;105(4):596-600
pubmed: 32565367
PLoS One. 2016 Mar 11;11(3):e0151224
pubmed: 26967734
Sci Rep. 2020 Aug 20;10(1):14031
pubmed: 32820179
Elife. 2020 May 11;9:
pubmed: 32392129
Clin Infect Dis. 2020 Jun 16;:
pubmed: 32548613
JAMA Netw Open. 2020 May 1;3(5):e209666
pubmed: 32437575

Auteurs

Victor H Ferreira (VH)

University Health Network, Toronto, Ontario, Canada.

Andrzej Chruscinski (A)

University Health Network, Toronto, Ontario, Canada.

Vathany Kulasingam (V)

University Health Network, Toronto, Ontario, Canada.

Trevor J Pugh (TJ)

University Health Network, Toronto, Ontario, Canada.
Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
University of Toronto, Toronto, Ontario, Canada.

Tamara Dus (T)

University Health Network, Toronto, Ontario, Canada.

Brad Wouters (B)

University Health Network, Toronto, Ontario, Canada.

Amit Oza (A)

University Health Network, Toronto, Ontario, Canada.

Matthew Ierullo (M)

University Health Network, Toronto, Ontario, Canada.

Terrance Ku (T)

University Health Network, Toronto, Ontario, Canada.

Beata Majchrzak-Kita (B)

University Health Network, Toronto, Ontario, Canada.

Sonika T Humar (ST)

University Health Network, Toronto, Ontario, Canada.

Ilona Bahinskaya (I)

University Health Network, Toronto, Ontario, Canada.

Natalia Pinzon (N)

University Health Network, Toronto, Ontario, Canada.

Jianhua Zhang (J)

University Health Network, Toronto, Ontario, Canada.

Lawrence E Heisler (LE)

Ontario Institute for Cancer Research, Toronto, Ontario, Canada.

Paul M Krzyzanowski (PM)

Ontario Institute for Cancer Research, Toronto, Ontario, Canada.

Bernard Lam (B)

Ontario Institute for Cancer Research, Toronto, Ontario, Canada.

Ilinca M Lungu (IM)

Ontario Institute for Cancer Research, Toronto, Ontario, Canada.

Dorin Manase (D)

University Health Network Digital, Toronto, Ontario, Canada.

Krista M Pace (KM)

University Health Network Digital, Toronto, Ontario, Canada.

Pouria Mashouri (P)

University Health Network Digital, Toronto, Ontario, Canada.

Michael Brudno (M)

University Health Network Digital, Toronto, Ontario, Canada.

Michael Garrels (M)

University Health Network, Toronto, Ontario, Canada.

Tony Mazzulli (T)

Sinai Health System, Toronto, Ontario, Canada.

Myron Cybulsky (M)

University Health Network, Toronto, Ontario, Canada.

Atul Humar (A)

University Health Network, Toronto, Ontario, Canada.

Deepali Kumar (D)

University Health Network, Toronto, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH